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ABSTRACT
Bone marrow-derived cells (BMDCs) have significant plasticity allowing
them to give rise to various non-hematopoietic cell types including epithelial cells of
the lung, liver, gut, and skin. These findings offer tremendous possibilities for the
use of cell therapy to treat tissue injury and disease. However, the specific
populations of cells responsible for this phenomenon are still unclear with
considerable controversy over the mechanism of this transformation.
In this study, we sought to compare the epithelial engraftment ability of two
populations enriched for hematopoietic stem cells (HSCs), specifically the
fractionated, lineage-depleted, and homed subset (FLH) and the lineage-Sca-1+c-Kit+
sorted population (LSK), to whole bone marrow (WBM). Plasticity capability was
assessed by examining the engraftment of type II (T2) pneumocytes in the lung
following sex-mismatched bone marrow transplantation in mice. The recipient mice
were knockouts of surfactant protein C (SPC), a T2-specific protein, thereby
allowing detection of the transplanted wild-type cells in the lung using
immunofluorescence for SPC on paraffin sections and cytospins. Additionally,
quantitative PCR (qPCR) for SPC transcripts provided a sensitive method of
detecting engraftment of these BMDCs.
Our data suggest that the FLH and LSK populations engraft in the lung at
least as well as the control WBM. Despite our effective detection techniques, only
exceedingly rare donor-derived T2 cells could be found by both microscopy and
qPCR. Therefore, fluorescence-activated cell sorting (FACS) of the digested lung was
tested and found to be reliable in isolating and enriching for these conversion
events.
Vav ancestry mice were also utilized in a similar transplantation model to
directly evaluate the engraftment ability of the hematopoietic and nonhematopoietic fractions of the bone marrow. Preliminarily, the hematopoietic
populations showed higher levels of epithelial engraftment by both
immunofluorescence and qPCR. Interestingly, a second dose of targeted lung
irradiation was necessary to elicit this effect suggesting that greater levels of tissue
damage may be necessary for this model's success.
When taken as a whole, our results seem to implicate HSC subpopulations as
enriched for highly plastic cells which are able to engraft as T2 cells in the lung. The
mechanism behind this conversion still remains to be studied but we hypothesize
that both cell fusion and incidental entrapment of transplanted BMDCs are
responsible.
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INTRODUCTION
Lung Structure and Function
The lung's primary function is to exchange gases, predominantly oxygen and
carbon dioxide, between inspired air and blood. This respiratory function occurs in
the distal most regions of the lung in alveolar sacs that are the blind ends of the lung
parenchyma but contiguous with the outside world. Alveoli are the site of gas
exchange and, in cross-section, appear open and with incomplete walls. There is a
rich capillary network associated with each alveolar sac. To separate the capillary
endothelial cells from the alveolar lining epithelial cells, there exists a very thin
basement membrane and surrounding interstitial tissue.
Alveolar epithelium itself is a continuous layer composed of two principal
cells types: type I and type II pneumocytes. Type I cells appear flattened, plate-like,
with small nuclei, scant cytoplasm and cover 95% of the alveolar surface while
comprising only 8% of the total cells in the lung. This specialized morphology makes
these cells highly optimized for gas exchange. In contrast, type II (T2) cells are
secretory cells with osmiophilic lamellar bodies containing surfactant. In addition to
producing surfactant, T2 cells are the main cell type involved in the repair of
alveolar epithelium after destruction of type I cells. It is for this reason that T2 cells
are sometimes considered the intra-organ stem cells of the respiratory unit since
they can give rise to type I cells along with additional type II cells.
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Alveolar macrophages also reside in the alveoli loosely attached to the
epithelial cells or lying free within the alveolar spaces. Microscopically, these
macrophages are large, pleomorphic, and heterogeneous in cell shape and surface
morphology. These cells are derived from blood monocytes and belong to the
mononuclear phagocyte system. They are often filled with carbon particles and
other phagocytosed material (1).

Surfactant Protein C (SPC)
Pulmonary surfactant is a complex mixture of lipids and proteins that
reduces surface tension, increases compliance, minimizes fluid accumulation, and
maintains alveolar size (2). Surfactant is secreted at the air-fluid interface in the
lung by T2 pneumocytes along with the non-ciliated columnar epithelium of the
larger airways. The surfactant apoprotein itself is bound to the lipid
dipalmitoylphosphatidylcholine such that secreted surfactant contains both
hydrophobic and hydrophilic regions. While surfactant proteins A, B, and D have
been detected in multiple organs (such as the blood and gastrointestinal tract),
surfactant protein C mRNA and protein have only been noted to be produced and
secreted by the T2 cell in the lung (3). This makes SPC an ideal reporter protein for
type II pneumocyte structure and function.
Whereas surfactant protein B (SPB) gene deletion is lethal in early life (4),
SPC knockout mice demonstrate a more subtle phenotype in which there are
abnormalities in lung elasticity and stabilization of other surfactant proteins. In
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humans, SPC deficiency results in adult onset interstitial lung disease that may be
related to abnormal processing of SPC protein which leads to its accumulation in T2
cells (5). The murine models mirror this result with chronic inflammation leading to
increased lung fibrosis, emphysema, and dysplastic T2 cells (6, 7).

Stem Cells
Stem cells hold great promise for the future approaches to medicine in the
areas of regenerative medicine, cell-based tissue repair in cancer treatment, and
gene therapy (8). Many tissues are candidates for therapeutic treatment but a better
understanding of general biological principles in these unique cells is necessary
before this vision can materialize (9). Even with our currently incomplete level of
understanding, the biology of hematopoietic stem cells in particular has led to a
number of medical advances in cancer therapy, transplantation, and autoimmunity.
Stem cells are biological units which are responsible for the development and
regeneration of tissues and organ systems. Since the 1960s, stem cells are generally
defined as clonogenic cells, which are capable of both self-renewal and multilineage
differentiation at the single cell level (10). There are many categories of stem cells,
which are mostly human semantic constructions to deal with the complexity of
these diverse entities. Stem cells can be divided into a long-term subset, capable of
infinite self-renewal, as well as a short-term subset that self-renews for a defined
interval. Stem cells also undergo differentiation and must give rise to non-self
renewing oligopotent progenitors. The earliest stem cells in ontogeny (those from
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the zygote to the inner cell mass of the blastocyst) are classified by their
developmental potential as totipotent meaning that they are able to give rise to all
embryonic and extra-embryonic cell types. Embryonic stem cell lines, which are
derived from the inner cell mass of the gastrula, are considered pluripotent in that
they can give rise to all three germ layers of the embryo but not the extra-embryonic
tissues. Adult stem cells are believed to be more restricted in their differentiation
ability and merely able to regenerate specific cells types within a tissue; type II
pneumocytes of the lung, gastrointestinal crypt cells, and oval cells of the liver
demonstrate this capacity.

Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) are a well-studied population, with a single
HSC being capable of reconstituting the entire hematopoietic system following an
otherwise lethal dose of radiation (11). These HSCs are very rare in mice and
account for approximately 1 in 100,000 nucleated cells in the bone marrow (12-14).
In order to study and characterize these cells, multiple isolation protocols have been
developed. Typically these protocols begin with a lineage deletion step in which
cells displaying surface markers consistent with mature lineages are removed. The
lineage removal antibody cocktail contains Ter-119 for erythrocytes, CD11b for
macrophages and granulocytes, CD3 for T-cells, and B220 for B-cells. This resulting
lineage-negative population is enriched for HSCs 10- to 100-fold. This linpopulation can then be further purified for HSCs using CD34+ cells (15), c-
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Kit+Thy1loSca-1+(KTLS) (16), or exclusion of rhodamine and Hoechst dyes
(RhodamineloHoechstlo) (17). But cell surface markers are not the only way to
isolate potential HSCs. A protocol which utilizes cell migration and survival involves
purifying lin- cells, and then separating this population based on size using an
elutriator. These cells are then injected into a lethally irradiated recipient mouse.
After 48 hours the cells that were able to home to the bone marrow are collected as
so called elutriated, lineage-depleted, and homed cells (ELH) (18). A single KTLS or
ELH cell can provide long-term hematopoietic reconstitution in about 20% of
lethally irradiated mice (16, 19).
The same purification techniques that enrich for HSCs also enrich for cells
that are capable of engraftment as epithelial cells. Since there is no evidence yet that
these cells were ever committed to hematopoiesis prior to their differentiation into
epithelial cells, these cells will be referred to as bone marrow-derived cells (BMDC),
and cells that are committed to hematopoiesis (e.g. KTLS) as HSCs. Until it is proven
that a cell can be committed to hematopoiesis, and then differentiate into a mature
functional epithelial cell without fusion, the term “transdifferentiation” will not be
used.

Plasticity
Many exciting discoveries have demonstrated that BMDCs have more
potential than previously suggested. In fact, they have been shown to develop into
tissue specific cells in the lung (19-23), heart (24), brain (25), skeletal muscle (26,
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27), bone (28), liver (29, 30), kidney (31, 32), pancreas (33, 34), eye (35), skin (36),
and gastrointestinal tract (37). This phenotypic flexibility is termed “plasticity” and
refers to the ability of adult stem cells to cross lineage barriers and adopt the
expression profiles and functional characteristics of cells unique to other tissues. In
1999, this transformation phenomena was first noticed in lethally irradiated female
rats and mice that had received male bone marrow cells. When examining the livers
of these animals, Y chromosome-positive hepatocytic oval cells were noted (30, 38).
This data has since been corroborated but with widely varying engraftment rates of
0.01 to 2%. This discrepancy is most likely due to the differences in experimental
conditions such as the number and type of cells transplanted, the methods of
detection, and the degree and type of liver injury. As more sophisticated methods of
detection were developed to reduce cell overlay and exclude blood and endothelial
cells (with CD45 and cytokeratin staining), the donor-derived hepatocyte
engraftment rate was revised to approximately 0.1% (39).

The Importance of Tissue Damage in the Lung
Many of these previous studies utilize some form of organ injury to induce
engraftment in mice. The best studied mechanism for lung damage is ionizing total
body irradiation at lethal levels greater than 1,000 cGy. At this dose, severe lung
injury occurs as demonstrated by capillary breakdown and extravasation of
erythrocytes into the alveolar spaces. This damage worsens from day 0 to day 5
with restoration of alveolar septal integrity by about day 7. This high level of injury
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is necessary for BMDC to engraft as lung epithelial cells while lower doses of greater
than 400 cGy were conducive to high rates of hematopoietic engraftment (40). This
data demonstrate a threshold effect for inducing lung damage such that BMDC can
engraft in this niche.
Bleomycin is another agent which has been used to induce lung injury.
Bleomycin is a glycopeptide antibiotic, which is used clinically as a
chemotherapeutic. However, it is also one of the most extensively studied and
reproducible experimental models for lung fibrosis. When bleomycin is delivered
into the airway, it produces acute lung epithelial injury, followed by a prolonged
inflammatory response which leads to lung fibrosis that eventually resolves (41).

Bone Marrow-Derived Cells in the Lung
Early work in the field of lung engraftment demonstrated that bone marrow
cells (specifically mesenchymal precursor cells) could adopt a collagen producing
phenotype in the murine lung (42). However, the first evidence that BMDCs could
become lung epithelial tissue was published in 2001 (19). These experiments used
lethally irradiated mice which were then transplanted with a single sex-mismatched
ELH HSC. At the time of sacrifice 11 months later, multiple epithelial compartments
were populated with Y chromosome containing cells which must be the progeny of
this originally transplanted ELH cell. In particular, the bronchi and alveoli showed a
significant amount of engraftment (12.58% and 2.32%, respectively). This outcome
was observed using colocalization of FISH staining for Y chromosome along with
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either FISH for SPB or immunostaining for SPB. However, a follow-up study by a
different group utilizing multiple different methods (e.g., starting donor cell,
detection methods, timing at sacrifice) was unable to reproduce these results (43).
Mirroring the initial findings by Krause et al (19), Theise et al (22) used the
CD34+Lin- subset of HSCs and a shorter time to sacrifice of 5 days to 6 months. They
found similar results that donor-derived cells had engrafted as 2%-14% of the total
type II pneumocytes. Grove et al (21) expanded the clinical implications of these
techniques by demonstrating that HSCs could be delivery vehicles for gene therapy.
They used whole bone marrow enriched for HSCs using 5-FU and then retrovirally
transfected the eGFP gene before systemically injecting the cells into a irradiated
host. Donor-derived T2 cells, which also stably expressed eGFP, were found in all
recipients at time points from 2 to 11 months.
In contrast to these results, Kotton et al (20) intravenously delivered lacZlabeled, plastic adherent mesenchymal stem cells (MSCs) after bleomycin-induced
lung injury. They detected marrow-derived cells engrafted as type I cells by
morphological and molecular phenotype but no T2 pneumocytes. Using the same
model, Ortiz et al (23) showed that donor MSCs localized to the zones of bleomycin
tissue injury and reduced fibrotic and inflammatory damage. However, the low
numbers of donor-derived cells engrafting the lung did not appear sufficient to
account for the therapeutic response, suggesting that donor stem cells may have
other local effects mediated through paracrine factors (44).
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Nevertheless, there are numerous studies to the contrary utilizing
discernibly different methods to demonstrate a lack of plasticity for adult stem cells.
Wagers et al (43) used two approaches to test their hypothesis: a chimeric mouse
produced via bone marrow transplantation with GFP-expressing KTLS HSCs, and
parabiotic animals which joined the circulation of a transgenic GFP mouse and a
wild type mouse. Both groups had the expected reconstitution or chimerism in their
hematopoietic system, but there was very little evidence for plasticity and
engraftment. In the transplantation approach, only 1 cell in 13.2 X 106 in the brain
and 7 cells out of 4.7 X 106 in the liver expressed the donor GFP marker.
Furthermore, there was no evidence of epithelial engraftment in the lung. Similarly,
the parabiotic model demonstrated no HSC engraftment beyond the hematopoietic
system. But this result is not surprising given the need for tissue damage to elicit
engraftment as explained above.
Kotton et al (45) used an SPC-eGFP reporter mice as a donor and
transplanted either whole bone marrow or side population (SP) cells, which are also
enriched for HSCs. So called SP cells have the unique ability to efflux Hoechst dye, and
when examined by fluorescence-activated cell sorting (FACS) analysis they fall within a
separate population that is to the "side" of the rest of the cells on a dotplot of emission
data. Three months following irradiation, the mice were analyzed and, while they had
good hematopoietic reconstitution, there was no evidence of donor cells being T2
pneumocytes by either FACS, fluorescence microscopy, or real-time PCR.
Chang et al (46) added to the field by discovering that these supposedly SPC and
eGFP coexpressing cells were in fact microscopic artifact. Using deconvolution
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microscopy, which is able to render a three dimensional image of the lung, these
initially engrafted cells were actually false positives with endogenous SPC signal
residing just outside of the donor-derived eGFP expressing cells with less than 300 nm
separating the two.
An important aspect of plasticity studies is the number of variables which can
affect the conversion outcomes; the timing of the transplant and analysis, the cell dose
and number of cell infusions, the method of cell delivery, the functional state of the
marrow cell delivered, and the nature of the marrow population or subpopulation are
all influential. It should be noted that many of these negative studies utilized GFP
transgene expression alone, which has been shown to be a relatively insensitive method
of detection for BMDC lung epithelium because of inconsistent expression (47). Current
standards in this field demand either confocal or single-cell analysis of marrow-derived
epithelial cells to rule out the possibility of overlay. The addition of CD45 for
hematopoietic antigens to staining protocols is appropriate along with phenotypic
analysis of epithelial cell-specific markers to reduce microscopy artifact (39). A
summary of publications on this topic can be seen in Table 1.

WBM/HSC

Adh BM

MSC

INTRODUCTION

Cells/route

Damage model

Findings

IV
IV
In vitro

Irradiation
Bleomycin
Co-culture

(42)
(20)
(48)

IV

Bleomycin

IV
6h post Bleo

Bleomycin ±
busulfan

In vitro

Co-culture

Engraftment of collagen transgene producing cells
Type I (potential artifact)
BMDE, fusion
Engraftment (epithelial-like cells) w/ Bleo
 Fibrosis
 Survival/repair
 G/GM-CSF
 Inflammatory cytokines
Epithelial-like morphology, CFTR+ epithelial cells
in vitro

IV
(WBM too)

Naphthalene

Rare airway epithelial cells (CFTR+)

(51)

IT

LPS IT

IV

IP LPS

Adherent BM
(7d)

IP Naphthalene

BMDE cells identified after damage

(53)

IV
IV
IV
IV
IV
IV
Parabiosis
IV

Irradiation
Irradiation
Irradiation
Irradiation
LPS
Irradiation
None
Irradiation

Rare BMDE cells
BMDE by concurrent Y-FISH, CK, and SPB
BMDE by concurrent Y-FISH, CK, and SPB
GFP+ alveolar epithelial cells
GFP+ alveolar epithelial cells

(54)
(19)
(22)
(21)
(55)

No BMDE

(43)
(45)

IV

Irradiation

SP/IV

Polidocanol IT

No BMDE
No BMDE (deconvolution microscopy revealed
false positive cells)
0.83% tracheal epithelium

IV (rat) BMT

Asbestos

Epithelial cells, BADJ localization

(57)

IV (human)
BMT

Chemotherapy

Epithelial cells, endothelial cells

(58)

IV (SP cells)

Irradiation

IV
Parabiosis
Other
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Circulating
precursor
Type II IT
Circulating
precursor

Radiation +
elastase
Radiation 
elastase
Tracheal
transplant
Bleomycin
Lung transplant
(human)

 Survival/repair
 Inflammation/edema
Prevention of LPS induced
inflammation/injury/edema

Type I, alveolar cells, rare bronchial epithelium,
but not Type II engraftment
↑ Engraftment and BMD cell repair following
ATRA and G-CSF treatment

(23)
(49)
(50)

(31)
(52)

(46)
(56)

(59)
(60)

Type I cells

(61)

Recipient-derived epithelial cells

(62)

Decreased fibrosis, Y+ cells localized to fibrosis
Epithelial cells
Epithelium in bronchi and alveoli

(63)
(64)
(65)
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Table 1: Summary of Publications Discussing Bone Marrow-Derived Epithelial
Cells in the Lung
Figure adapted from Krause (66). References are in the last column. Abbreviations:
intravenous (IV), intratracheal (IT), intraperitoneal (IP), bone marrow
transplantation (BMT), Bleomycin (Bleo), Y chromosome positive (Y+), side
population (SP), hematopoietic stem cell (HSC), whole bone marrow (WBM), bone
marrow derived epithelial cell (BMDE), day (d), cytokeratin (CK), surfactant protein
B (SPB), alveolar macrophage (AM), lipopolysaccharide (LPS), granulocyte colony
stimulating factor and granulocyte macrophage colony stimulating factor (G/GMCSF), broncho-alveolar duct junction (BADJ), all-trans retinoic acid (ATRA). All
studies performed in mice except where indicated.
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Bone Marrow-Derived Epithelial Cells in Humans
The appearance of bone marrow-derived epithelial cells is not just a research
anomaly seen in experimental animals. When liver tissue from two women who had
undergone bone marrow transplantation from male donors was examined, Y
chromosome-positive hepatocytes could be identified in up to 12% of the liver
specifically around the periportal area (67). Interestingly, the highest rates of
engraftment could be seen in a separate patient who had developed recurrent
hepatitis C infection. This again demonstrates that severe tissue injury can serve as
a necessary impetus for significant engraftment.
With regards to the lung, Suratt et al studied (58) lung specimens from
biopsy or autopsy from two female patients that had pervious sex-mismatched bone
marrow transplants. They found chimerism in the alveoli with donor-derived
epithelium (2.5-8.0%) and endothelium (37.5-42.3%) when merging images for Y
chromosome FISH along with immunohistochemistry for cytokeratin (epithelial
marker) and CD31 (endothelial marker). Of interest, there was a third patient
examined in this series which did not demonstrate epithelial or endothelial
chimerism but this patient was unique in that she had not received a conditioning
regimen of total body irradiation. These findings have been echoed in other
experiments in which lung transplantation recipients were seen to have recipientderived type II (9.1-20%), bronchial epithelial (5.7-25.5%), and glandular (9.124.2%) cells (65). These robust results have since been tempered in a more recent
study which demonstrated T2 cellular engraftment in the lung to be between 0%
and 0.55% (68).
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Functional Effects of Bone Marrow-Derived Cells
Although there has been significant discussion concerning the importance of
these plasticity observations (69), in at least a few models it has been shown that
these BMD epithelial cells can be quantitatively significant and functionally relevant.
Lagasse et al (70) used a fumarylacetoacetate hydrolase (FAH) knockout mouse,
which is an experimental model for hereditary tyrosinemia type 1. These mice
necessarily die from liver failure due to the buildup of toxic metabolites of tyrosine.
Amazingly, purified FAH+ KTLS HSCs and adult bone marrow cells could produce
large numbers of functional hepatocytes (30-50% of liver mass) that were able to
restore the biochemical function of the liver and rescue the mice from liver failure
and certain death.
Orlic et al (24, 71, 72) have also shown that directly injected whole bone
marrow or c-kit+ BM cells could restore some cardiac function in mice with
myocardial infarctions. The Krause lab has published data proving that BM-derived
gut epithelial cells can partially restore functional electrophysiological activity to
the GI tract of cystic fibrosis transmembrane regulator (CFTR) knockout mice (73).
Additionally, Zhao et al (74) demonstrated that human BMDCs can ameliorate
stroke manifestation in rats. Interestingly, the beneficial effects of these cells in
ischemia injury are not necessarily due to epithelial engraftment but rather could be
the result of altered cytokine expression or engraftment as endothelial cells. This
source of controversy remains an open question.
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BMDCs have also been shown to be beneficial in a model of ischemic renal
disease by differentiating into renal tubular cells (75). Wild-type mice underwent
BM transplantation using Lin-Sca-1+ cells ubiquitously expressing β-galactosidase,
and then were subjected to a period of renal ischemia by surgical clamping of the
renal artery. The normal rise in blood-urea-nitrogen (BUN) concentrations induced
by renal ischemia was significantly reduced in mice after transplantation with the
Lin-Sca-1+ cells compared with controls. Furthermore, β-galactosidase-positive
renal tubule epithelial cells were present as early as 48 hours after ischemic injury,
which correlated with the protective effect. In contrast, no β-galactosidase-positive
renal tubules were present in mice whose renal ischemia was preceded by the
transplantation of Lin+ cells. The epithelial phenotype of the β-galactosidasepositive cells was confirmed by immunohistochemistry for megalin (a surface
marker of tubular epithelia) and the lack of CD45 expression.
Functional effects of BMDCs in the lung have also been demonstrated.
Inflammatory responses induced by either lipopolysaccharide (55) or elastase (60)
could be reduced in the lung with the supplementation of BMDCs. Both of these
papers used radiation conditioning as a precursor to bone marrow transplantation.
It is suggested that the improvement in respiratory pathology is due to the
temporary engraftment of type I, type II, and endothelial cells. However, both these
studies have weaknesses because they lacked relevant non-irradiated controls.
A significant survival advantage was also conferred by administering BMD
mesenchymal cells into mice that were myelosuppressed and then injured with
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bleomycin (49). In these mice, BMDCs engrafted as both type I and type II
pneumocytes. This protection was also associated with increased circulating levels
of G-CSF and GM-CSF (known for their ability to promote the mobilization of
endogenous stem cells) and with a decrease in inflammatory cytokines. However,
this study raises the question whether epithelial engraftment itself or induction of
reparative growth factors played the major role in protection from injury and
fibrosis. All these studies seem to suggest that engrafting BMDCs are most beneficial
in response to acute injury caused by genetic deficiency, infarction, or exogenous
toxin. A summary of relevant literature is again presented in Table 1.

Vav Ancestry Mice
The vav protein was first described as an adapter protein based on its SH3
domains without an obvious enzymatic domain. However, it has since been
determined that vav also plays critical roles in signaling via GTPase and other
pathways (76). The particular usefulness of the vav protein promoter sequence lies
in the demonstration that only cells committed to hematopoiesis express this
sequence. Stadtfeld et al (77) first created transgenic mice, called vav ancestry mice,
that express Cre recombinase on the vav promoter. When the vav ancestry mice are
crossed with a Cre reporter strain that expresses YFP only after Cre-mediated
excision, any cell that ever expressed vav would permanently express YFP (unless
there was chromosomal deletion or promoter inactivation).The investigators used
this tool in an effort to directly test whether cells that have committed to the
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hematopoietic lineage are able to differentiate into epithelial cells normally in vivo.
They hypothesized that if cells committed to hematopoiesis became hepatocytes or
endothelial cells in vivo, then YFP-positive cells would be detectable over time
without the need for tissue injury. Indeed they did find a very rare YFP+ hepatocyte
(1/75,000) but no YFP+ endothelial cells.
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STATEMENT OF PURPOSE
Bone marrow-derived cells have significant plasticity allowing them to give
rise to various non-hematopoietic cell types including epithelial cells of the lung,
liver, gut, and skin. These findings offer tremendous possibilities for the use of cell
therapy to treat tissue injury and disease because BMDCs may represent a
renewable pool of epithelial precursors. At present, bone marrow to epithelial cell
engraftment levels in the lung are too low to be of clinical relevance. However, if
these levels could be increased, there could be multiple therapeutic implications of
this work. By better understanding the capabilities of subpopulations involved and
the mechanisms by which they become epithelial cells, we will be able to design
strategies to increase engraftment of these cells. Theoretically autologous BMDCs
with the capacity to differentiate into mature pulmonary cells could be isolated and
cultured in vitro to serve as target cells for gene therapy or as a resource for organ
reconstitution and repair. However, selective long-term delivery of genes to the lung
has not yet been highly successful. The immediate targets of these gene therapy
projects could include inherited diseases of the respiratory tract such as surfactant
protein deficiencies, cystic fibrosis, idiopathic pulmonary fibrosis, or α-1 antitrypsin
deficiency.
Based on currently available evidence in the murine model, it is not clear if
purified stem cell populations offer an engraftment advantage in the lung compared
to whole bone marrow. Therefore, we designed an experiment to compare the use of
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whole bone marrow to ELH and LSK populations to determine if any one group
offers a higher conversion rate. A summary of experimental design is presented in
Figure 1. Using SPCKO mice as recipients and WT mice as donors for
transplantation, SPC mRNA and protein can be used as a donor-derived T2
pneumocyte cell marker measuring engraftment. Untransplanted SPCKO and WT
mice were included as negative and positive controls, respectively. Additionally as a
negative control for transplantation and radioprotection cell effects, SPCKO whole
bone marrow cells were transplanted into an SPCKO recipient. The mice were
sacrificed and analyzed three months later. We hypothesize that the ELH population
by virtue of its homing ability will show improved engraftment when compared to
WBM and LSK populations.
In this investigation, SPC production was detected by using
immunofluorescence on paraffin and cytospin digestions of the lung. To
complement these studies, quantitative PCR for SPC was utilized on the digested
lung. These mice were also assessed for hematopoietic engraftment.
In an effort to investigate a better detection strategy for these rare BMD T2
cells, FACS analysis from GFP-positive donor mice into wild-type recipients was
tested. The resulting donor-derived lung cells were then examined by confocal
microscopy.
Lastly, to explore the potential of different BMD populations, the vav ancestry
mice were used as donors into lethally irradiated SPCKO recipients. Specifically, this
design allowed a comparison of engraftment capability between hematopoietic and
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non-hematopoietic cell types, which are both resident in the bone marrow. The
hematopoietic and non-hematopoietic fractions were divided based on vav-YFP
expression using FACS. Again SPC mRNA and protein were used as a donor-derived
T2 cell marker. The WBM population served as the control. The mice were sacrificed
and analyzed one month later. We hypothesize that the YFP+ population
representing the hematopoietic population will show better engraftment based on
the previously purported plasticity of HSCs. Additionally, this transplantation model
was used to determine if engraftment of these donor cell groups could be enhanced
through a second dose of targeted lung irradiation. A summary of this experimental
design is presented in Figure 2. We hypothesize that a second round of irradiation
could further enhance engraftment by inducing additional damage and
opportunities for BMDCs to engraft.
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Recipient
Untransplanted Controls:
SPCKO
WT

♀ 106 WT WBM

♀ 106 SPCKO WBM

1000 cGy
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+ ♂ 100K SPCKO WBM
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+ ♂ 100K SPCKO WBM
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Figure 1: Schematic Showing the Experimental Design and Analysis
Panel A presents the transplantation scheme. NB The number of transplanted mice
is not equal to the final number of mice analyzed due to expected animal loss.
Panel B shows the analysis steps for each animal.
Panel C is a table showing the interpretation of immunofluorescence patterns of
lung cells seen under microscopy.
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A

B
Donor Animal

Donor Populations

Recipient

106 Unsorted WBM
1000 cGy
X 7 Mice

vav-Cre YFP

2 X 106 FACS-sorted YFP+

1 month

Analyze Lungs for
SPC mRNA and
Protein

SPCKO

1050 cGy

5 X 105 FACS-sorted YFP+ 106 SPCKO WBM

½ of Mice Receive 2nd
Dose of Lung Irradiation

Figure 2: Schematic Showing the Experimental Design for Vav Ancestry
Studies
Panel A demonstrates the genetic design of vav ancestry mice. At top, the vav-Cre
bicistronic transgenic vector showing the hypersensitivity sites (HS) of the vav
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elements, the insulator sequences (INS), and the IRES-YFP element which is not
functional in vivo (as indicated by the lowercase letters). The middle and bottom
sequences show the ROSA26R-YFP locus floxed before and after Cre-mediated
excision of the stop cassette. The resultant F1 generation expresses YFP only in the
hematopoietic system. Figure adapted from Stadtfeld et al (77).
Panel B presents the experimental transplantation schemes. NB The number of
transplanted mice does not equal the final number of mice analyzed due to expected
animal loss following irradiation.
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METHODS
Transgenic Mice
SPC knockout mice (SPCKO) were obtained from the laboratory of Dr. Jeffrey
Whitsett (Children’s Hospital, Cincinnati, OH). These mice were generated by
targeted insertion of a 5.6 kB PKG Neomycin cassette into the polyvaline region of
exon 2 that gives SPC its hydrophobic functional properties. These mice completely
lack mRNA by Northern blot and RT-PCR, and protein by Western blot for mature
SPC and immunohistochemistry (IHC) for pro-SPC. On a 129/Sv background, this
deletion confers regional emphysema and interstitial pneumonitis with respiratory
insufficiency (7). Wild-type 129/SvJ mice were used as donors and controls and
obtained from The Jackson Laboratory (Bar Harbor, ME).
The experiment involved with isolating engrafted type II pneumocytes by
FACS utilized constitutively expressing eGFP mice under the ubiquitin-C promoter
on a C57BL/6 background which were donated by Jiankan Guo (Yale University,
New Haven, CT). Recipient mice were C57BL/6J-Tyrc-2J/J albino mice that carry a
mutation in the tyrosinase gene. This alteration results in a complete absence of
pigmentation in the skin, hair, and eyes, which was irrelevant for this study (The
Jackson Laboratory).
Vav ancestry mice were previously described by Stadtfeld et al (77). The
details of their construction has already been presented in the Introduction,
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Statement of Purpose, and Figure 2 of this work. These mice were the gift of Thomas
Graf (Albert Einstein College of Medicine, New York, NY). Basically, vav ancestry
mice were created by crossing vav-Cre transgenic mice with ROSA26R-YFP reporter
mice. Mice with YFP+ cells of dendritic morphology were classified as vav ancestry
mice. These mice were then bred for homozygosity on a C57BL/6 background by
crossing female vav ancestry mice with male ROSA26R-YFP.

Stem Cell Isolations
(The FLH isolations were performed with the collaboration of Lin Wang.)
Donor animals were anesthetized using isoflurane, sacrificed by cervical
dislocation, limbs removed, and bone marrow harvested by crushing the bones with
mortar and pestle in 3% fetal bovine serum (FBS) in phosphate buffered saline
(PBS).
Fractionated, lineage-depleted, and homed (FLH) cells were harvested using
a multi-step process based on the previously described ELH technique by Krause et
al (19) with slight modifications. Without a functional elutriator, harvested cells
were separated based on size using a percoll gradient. The purified HSCs reside at
the bottom of the 3rd fraction corresponding to a density of 1.081-1.087 g/ml.
Instead of using "rotor-off" cells as previously published, short-term reconstituting
radioprotection cells were provided by unfractionated whole bone marrow cells
identical to the recipient.
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In a summary of the following steps, these cells were then depleted of mature
differentiated hematopoietic cells using immunomagnetic lineage depletion cocktail
against Ter-119 for erythrocytes, CD11b for macrophages and granulocytes, CD3 for
T-cells, and B220 for B-cells (BD Biosciences, San Jose, CA) as described in the BD
iMag Cell Separation System protocol. The resultant population was labeled with the
fluorescent tracking dye PKH26 (Sigma-Aldrich, St. Louis, MO) and transplanted into
lethally irradiated (1100 cGy) recipient mice. Two days after transplantation, the
bone marrow was harvested using the crushing technique from the primary
recipient, and PKH26+ cells that have homed to the bone marrow were collected by
FACS. A summary of this purification is presented in Figure 3. These FLH cells are
then used for further transplantation studies.
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FLH Cells
Fractionated

Lineage Depleted

Homed
1100 cGy

Transplant
cells
48 hrs

Fraction 3 of
Percoll Gradient

Immunomagnetic
Enrichment of LinFraction

Label Lin- cells
with PKH26 dye

Harvest
PKH26+ BM
using FACS

Figure 3: A Schematic Representation of the Purification of FLH cells

The LSK population and its isolation have already been well described (78).
Briefly, whole bone marrow was erythrocyte lysed, lineage depleted using
immunomagnetic separation (as above), and then sorted using FACS for cell surface
markers. The lineage depleted cells were stained at the standard concentration of 1
µg/ 1 million cells with Sca-1 Alexa 647, c-Kit PE-Cy7, and biotinylated lineage mix
PE F9 (BD Biosciences). The first gate collected living cells of appropriate size and
granularity using forward and side scatter. The second gate sorts for the lineagefraction. Finally these cells were sorted to contain the Sca-1+c-Kit+ fraction. A sample
of the results for this sort can be seen in Figure 4.
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Six week-old vav ancestry mice were sacrificed and their bone marrow
harvested using the crushing technique. As with the LSK cell isolation, the whole
bone marrow was then erythrocyte lysed and sorted using FACS. This time cells
were stained for CD3 PE (BD Biosciences) as a marker for T cells. After forward and
side scatter gating, the CD3- fraction was used in an effort to reduce T cells and the
possibility of donor and recipient incompatibility. This was a remote concern since
the donor mouse is on a C57BL/6 background and the recipient mice are on a
129/SvJ. Our lab's experience suggests that there is no risk of rejection or graft
versus host disease, but this precaution was still taken. YFP positive and negative
populations were separated using endogenous fluorescence and the resultant CD3YFP+ and CD3-YFP- populations used for transplantation. A sample of the results of
this sort can be seen in Figure 4.
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Figure 4: FACS Data Demonstrating LSK and Vav-Cre YFP Separations
Panel A contains a representative FACS plot for LSK sorts. The P1 polyhedron
contains the living cells based on forward and side scatter. The P4 fraction contains
the lineage negative cells. The P5 rectangle represents the final lineage-Sca-1+c-Kit+
population which was transplanted. This population represents ~26,000 cells or
about 3.4% of starting input. This was the typical yield for this population.
Panel B contains a representative FACS plot for vav-Cre YFP sorts. Again, the R1
polyhedron gates based on forward and side scatter for living cells. The R3 box
contains the CD3-YFP- fraction which is ~20,000 cells or about 5% of the starting
input. The R4 box represents the CD3-YFP+ fraction which contains ~261,000 cells
or about 65% of cells. Both the CD3-YFP- and the CD3-YFP+ populations were
transplanted as described in the experimental design. The R5 rectangle is used to
show the entire CD3- fraction but is not relevant in this study.
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Bone Marrow Transplantations
(Transplantations were performed with the assistance of Sharon Lin. The vav
ancestry studies performed with the collaboration of Susannah Kassmer.)
After myeloablation with 1000-1100 cGy total body gamma irradiation using
a Mark I-68A Cesium-137 Irradiator (JL Shepherd & Associates, San Fernando, CA),
6 to 8 week-old male SPCKO mice received isoflurane anesthesia and a 150 µl retroorbital injection of transplanted cells which were resuspended in Improved Minimal
Essential Medium (IMEM; Gibco) supplemented with 1X
penicillin/gentamicin/streptomycin (100 µg/ml). There were 4 donor groups all of
which were age-matched and sex-mismatched: 1 million unfractionated nucleated
wild-type 129/SvJ WBM cells (n=5), 1 million unfractionated nucleated SPCKO WBM
cells (n=5) as a transplantation control for radioprotection cells only, 1000 wildtype FLH cells along with 100,000 SPCKO WBM radioprotection cells (n=9), and
1000 wild-type LSK cells along with 100,000 SPCKO WBM radioprotection cells
(n=9) (refer to Figure 1). The basics of this method have been previously described
(40). Additional untransplanted controls included WT and SPCKO strains. (NB
Radioprotection cells must be transplanted in order for the mice to survive the
otherwise lethal dose of radiation. To reduce confounding, the number of cells
transplanted was determined to be the smallest number possible such that around
50% of the animals survive. These cells are identical to the recipient and typically
have a survival of less than 3 months which means that at the time of analysis they
should make no contribution to the surviving animal.) Following transplantation,
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the mice received sulfatrim and autoclaved food and water for 1 month, after which
they received routine daily care by the Yale Animal Resources Center (YARC).
A similar method was used for the investigations involving the isolation of
engrafted T2 pneumocytes using FACS sorting. Female albino 6 to 8 week-old
C57BL/6 recipient mice (n=14) were irradiated with 950 cGy and then transplanted
with 1 million male unsorted nucleated WBM cells from the ubiquitin-GFP+ mouse.
Injection was performed through the tail vein and 4 unirradiated/untransplanted
recipient mice were left as controls. These transplanted mice then underwent the
same care as above at YARC and were sacrificed and analyzed at a 6-month time
point.
The vav ancestry studies were also performed using similar methods and tail
vein injection. Recipient 6 week-old SPCKO mice (n=20) were irradiated with 1000
cGy and then transplanted with one of three populations from the vav ancestry
mice, which were age-matched and sex-mismatched: 106 vav-Cre YFP unsorted
nucleated WBM cells (n=8), 2 X 106 FACS-sorted CD3-YFP+ cells (n=7), or 5 X 105
FACS-sorted CD3-YFP- cells along with 106 unsorted nucleated SPCKO WBM for
radioprotection (n=5). (NB This last group needed supplemental SPCKO WBM cells
since the YFP- population does not contain hematopoietic cells and would have
otherwise died from radiation toxicity.) The unsorted vav-Cre YFP WBM population
served as the control against which the sorted populations would be compared. The
differing number of cells transplanted was a result of the differing values of cells
yielded after FACS analysis. These transplanted mice then underwent the same care

METHODS

COHEN 33

as above in YARC. At the 1-month time point, half of these animals were sacrificed
and analyzed. The other half experienced a second dose of targeted lung irradiation
at the 3-month time point. One month following this treatment, this group of
animals was sacrificed and analyzed.

Targeted Lung Irradiation
(Performed with assistance from Susannah Kassmer.)
Three months following transplantation of vav-Cre YFP bone marrow into
SPCKO recipients (n=8), the right lung was selectively irradiated with 1050 cGy
using a Siemens Stabilipan 250kV unit (Malvern, PA). Custom fit lead shields were
used to localize the dose of radiation.

Mouse Sacrifice and Lung Tissue Harvest
Mice were sacrificed at 3 months post-transplantation unless stated
otherwise. Mice were anesthetized with urethane IP injection and bronchoalveolar
lavage with 2 ml of PBS was performed using a 23G angiocatheter (BectonDickinson, Franklin Lakes, NJ) into the trachea. Then right ventricular perfusion was
performed using the standard method of a median sternotomy approach such that
the right heart is punctured with a 23g needle and flushed with 10 ml of PBS into
the pulmonary circulation. The lungs were then inflated with 1 ml of 1% low melt
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agarose in PBS at 42°C through the angiocatheter in the cannulated trachea. The
agarose was then allowed to cool and solidify over a couple of minutes.

Tissue Fixation and Cytospin Preparation
The murine right lung was placed into 4% buffered formalin for 4 hours and
then transferred to 70% ethanol prior to paraffin embedding and sectioning. The
left lung was divided into 2 pieces based on lobe segments. One piece was placed
into RNAlater stabilization reagent (Qiagen, Valencia, CA) and frozen in -80°C per
manufacturer's recommendations for later use in RNA isolation. The other piece
was used for single cell lung digestion, immunodepletion, and cytospins.
This preparation involved multiple modifications from the originally
described procedure by Corti et al (79). The resulting lung piece was minced with a
fresh razor blade then digested for 90 minutes at 37°C using a fresh 5 ml solution of
Dulbecco's Modified Eagle Medium (DMEM, Gibco, Invitrogen) supplemented with
dispase (2.4 U/ml, Roche), collagenase (133 U/ml Worthington Biochemical
Corporation, Lakewood, NJ), and DNAseI (100 U/ml, Roche). The digested tissue
was then ground through a 40 micron strainer (Falcon, Oxnard, CA) and the filter
flushed with an additional 5 ml of DMEM. The cells were centrifuged at 800g for 10
minutes and the supernatant removed. In order to remove erythrocytes, 2 ml of 1X
Pharmlyse (Pharmingen, San Diego, CA) was added for 5 minutes at room
temperature (RT) per the manufacturer's instructions. The cells were then washed
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in PBS, counted, and resuspended in 3 ml of PBS supplemented with 3% BSA and
5mM EDTA at 1,000,000 cells per ml.
The concentrated and digested lung cells were then immunodepleted using
magnetic bead separation per manufacturer's protocol (BD Biosciences). Antimouse CD45 and anti-mouse CD11b biotinylated antibodies (1µg/million cells)
were added to the cells and mixed so as to remove hematopoietic cells and
macrophages from the digestion. This mix was incubated at RT for 15 minutes then
streptavidin magnetic beads (5µl/million cells) were added and the entire solution
refrigerated at 4°C for 30 minutes. The contents were then placed in the BD iMagnet
for 8 minutes after which the CD45-CD11b- supernatant was removed and the cells
were counted.
The immunodepleted cells were then spun (20,000 cells/slide) onto
Surgipath (Richmond, IL) precleaned slides in a Thermo-Shandon cytospin
(Pittsburgh, PA) at 700 rpm for 7 minutes after which they were fixed in 4%
paraformaldehyde (PFA) for 15 minutes. The slides were rinsed with dH2O and air
dried at RT for at least 1 hour prior to storage at -80°C. From the starting population
of approximately 2 million lung cells per animal, typically greater than 300,000 cells
remained following immunodepletion.
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Immunofluorescence on Paraffin Sections and Cytospins
Slides were deparaffinized with heat at 60°C and washed with Citrisolve.
They were then rehydrated using successive ethanol baths of 100%, 95%, and 70%.
Following a brief wash with PBS, the sections underwent an antigen retrieval step if
necessary. This involved adding boiling BD Retrievagen citrate pH 6 solution (BD
Pharmingen, San Diego, CA) to the slides in coplin jars. The slides were then kept in
a steamer for 30 minutes and allowed to cool to RT, followed by a wash in 1X PBS
with 0.25% Triton-X for 10 minutes. The slides were blocked with 3% BSA in 1X
PBS with 0.25% Triton for 1 hour in a moisture chamber at RT and then incubated
overnight at 4°C with the primary antibody mix under a coverslip to localize the
antibodies and avoid evaporation. The primary antibody mix included either
polyclonal guinea pig α mouse SPC 1:1000 (courtesy of Jeffrey Whitsett) or
polyclonal rabbit α mouse pro-SPC 1:50 (Chemicon, Millipore, Billerica, MA).
Additionally, the mix contained rat α mouse CD45 and F4/80 in a 1:50 dilution (both
from Abcam, Cambridge, MA). Following a washing step with PBS/Triton, secondary
antibody mix of either α guinea pig or α rabbit AF488 at 1:500 and α rat AF 547 at
1:250 in blocking buffer was added for 1 hour at RT. The slides were again washed
and mounted with VECTASHIELD containing DAPI (Vector Labs, Burlingame, CA,
USA).
Cytospin slides were thawed to RT and permeabilized with PBS/Triton
before primary antibody mix was added. The subsequent steps were the same as for
the above paraffin section protocol. Antigen retrieval was never used on these
slides.

METHODS

COHEN 37

Microscopy
(Confocal work completed with the collaboration of Susannah Kassmer.)
Light microscopy was performed on an Olympus BX51 microscope equipped
with a SensicamQE camera. IPLAB software was used to capture images. Confocal
microscopy images were obtained on a Leica TCS SP5 Confocal Microscope
equipped with 405 Diode, Argon, Helium/Neon 543, and Helium/Neon 633 lasers.
These images were collected and analyzed by Leica LAS AF software. Confocal
microscopy with 3-dimensional z-stack analysis was used to reimage these cells. All
microscopic analyses were performed with the investigator blinded regarding the
identity of the slides analyzed.

RNA Isolation and Quantitative Real-Time PCR
All tools and surfaces were either autoclaved with diethylpyrocarbonate
(DEPC) water or treated with RNase Zap (Ambion, Austin, TX) prior to usage. Total
RNA was extracted from approximately 30 mg of lung tissue which was previously
stored in RNAlater. The RNeasy Mini kit (Qiagen) was used per manufacturer's
recommendations with the addition of an RNase-free DNase I (Qiagen) digestion
step to eliminate genomic DNA. The resultant RNA was qualified and quantified
using the NanoDrop ND1000 Spectrophotometer (Thermo Scientific, Wilmington,
DE), and then reverse transcribed using Superscript II Reverse Transcriptase
(Invitrogen) and random hexamer primers (Invitrogen) to create cDNA.
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Quantitative real-time PCR was performed using a BioRad CFX96 Real Time
System (Hercules, CA). Amplification was performed for 40 cycles (10 seconds
denaturation at 95°C, 30 seconds annealing at 60°C, and 30 seconds elongation at
72°C) using approximately 200 ng of cDNA in a SYBR green master mix (Applied
Biosystems) as directed. All reactions were performed in triplicate and any samples
that were greater than 1 cycle difference in their threshold calculation (termed C(t))
were repeated. Primer for ribosomal 18s or β2-microglobulin was used as the
internal control for total RNA content. All reactions included non-template controls,
non-reverse transcriptase controls for DNA contamination, WT positive control, and
SPCKO negative controls.
SPC primers spanned the disrupted exon 2 insertion site to the end of the full
length mRNA and were designed as follows: Fwd 5’-ATG GAG AGT CCA CCG GAT
TAC-3' and Rev 5’-ACA GAC TTC CAC CGG TTT CTG-3'. These primers amplify a 664
base pair fragment. 18s rRNA primers were designed as follows: Fwd 5'-CGG CTA
CCA CAT CCA AGG AA-3' and Rev 5'-GCT GGA ATT ACC GCG GCT-3'. β2microglobulin primers were designed as follows: Fwd 5'-CAT ACG CCT GCA GAG
TTA AGC A -3' and Rev 5'- GAT CAC ATG TCT CGA TCC CAG TAG-3'. All primers had a
melting temperature of 58-62°C. The difference in cycle threshold (termed Delta
C(t)) was calculated by subtracting the mean C(t) of 18s or β2 by the mean C(t) of
SPC for each individual sample. Statistical significance between groups was
confirmed at p-values less than 0.05 and calculated using the 1 tailed,
homoscedastic, t-test .
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FISH For Y-Chromosome
To determine levels of hematopoietic engraftment, blood smears and bone
marrow cytospins from sacrificed mice were prepared and fixed in formalin as
described above. The slides were washed with PBS, and Y-probe (developed by
degenerate oligonucleotide primed-PCR using 6AI primer = 5'-CCG ACT CGA GNN
NNN NTA CAC C-3' supplied by Lin Wang, Yale University) was added to heated
slides at 60°C and incubated overnight at 37°C. Following washes with 2X SSC, slides
were blocked with 4xSSC/3%BSA/0.1%Tween-20 for 30 min at 37°C, washed again,
and stained with anti DIG-rhodamine (Roche, Mannheim, Germany) at 1:10 in
blocking buffer for 45 minutes at 37°C . The detection solution was washed away
and the slides were mounted with VECTASHIELD including DAPI.

Fluorescence Activated Cell Sorting Analyses
All FACS sorts were performed on either a BD FACSAria Special Order System
or MoFlo XDP Cell Sorter (Beckman Coulter, Brea, CA). FACS data was analyzed with
FlowJo 8 Analysis Software (Ashland, OR). Regarding the GFP+ into wild type
transplantations, engrafted donor-derived T2 lung cells were described as
GFP+CD45-CD11b-CD31- and these cells were sorted onto a poly-L-lysine coated
glass bottom dish containing DMEM supplemented with 3% FBS and 1X
penicillin/streptomycin. The sorted cells were allowed to attach to the plate
overnight at 37°C and subsequently fixed with 4% PFA before being examined by
immunofluorescence as above.
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RESULTS
Establishing and Validating Methods
Before our experimental investigations, we had to determine that our
method of detecting target genes was satisfactory. In particular, we were concerned
with the sensitivity and specificity of immuno-staining for SPC in both paraffin-fixed
sections and single cell suspensions on cytospins. Wild-type mice (WT) lungs were
used as the positive control while knockout mice for SPC (SPCKO) lungs served as
the negative control. Various preparation techniques were utilized with or without
antigen retrieval. Additionally, two different antibodies (guinea pig-raised
polyclonal and rabbit-raised polyclonal, refer to Methods for details) were used to
assess the clearest staining with the least amount of background. The comparison of
these stainings in paraffin sections can be seen in Figure 5. As expected, the SPC
staining pattern was vesicular in nature and located in the cytoplasm. The brightest
staining for SPC in WT mice was observed using the guinea pig-derived antibody
without the use of antigen retrieval. This finding coupled with the lack of significant
background fluorescence seen in SPCKO mice made this combination most desirable
for future investigations, and determined that in our hands SPC positive T2 cells
could be detected.
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Figure 5: A Comparison of SPC Staining Protocols for Mouse Lungs
Four different combinations of antibodies and slide preparations are shown here.
WT images (in left panels) represent the positive control for SPC staining whereas
SPCKO is the negative control (in middle panels). Guinea pig antibody without an
antigen retrieval step seemed to yield the best results with definitively SPC-positive
cells in the WT and a low amount of background in the SPCKO. A magnified image of
the WT lung is shown to demonstrate the vesicular nature of SPC staining (right
panel). Staining: DAPI (blue) for nuclei, SPC (green) for T2 pneumocytes. Images
were produced using light microscopy on 40X objective magnification.
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Single cell digested cytospin stainings were also optimized in the same
manner as paraffin sections. Since these original lung digestions were unsorted (i.e.,
there was no lineage depletion step for contaminating blood cells) and T2 cell
morphology is lost during digestion, CD45 (a pan hematopoietic cell surface marker)
and F4/80 (a macrophage marker) staining antibodies were included. This
additional staining was of particular importance in recognizing macrophages, which
are known to show spurious SPC staining and mimic T2 pneumocytes, either due to
invagination of SPC in vivo or due to autofluorescence. Positive CD45 and F4/80
staining is typically diffusely distributed throughout the cell membrane and this
pattern was observed in many of the cells on these slides. Type II cells were
SPC+CD45-F4/80- which would make them appear green only; whereas
macrophages were either SPC-CD45+F4/80+ or SPC+CD45+F4/80+ resulting in a red
or yellow color, respectively, on multi-color merged images. Upon examination, the
same combination of guinea pig-derived antibody with no antigen retrieval resulted
in the clearest cytospin data as seen in Figure 6. These cytospins provided excellent
visualization of the WT positive controls and the SPCKO negative controls; however
the rarity of BMDC in the next experiments will necessitate an additional selection
step to enrich for T2 cells.
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Figure 6: Successful SPC, CD45, and F4/80 Staining of Lung Cytospins
Two examples of clear staining with SPC, CD45, and F4/80 using positive (WT in left
panels) and negative (SPCKO in right panels) control slides. The WT slides
contained many SPC+CD45-F4/80- cells, which are T2 pneumocytes while the
knockout slides did not have any SPC+ cells. Many blood and tissue macrophages can
be seen in these images as CD45+F4/80+. These results validated that our detection
techniques will be sufficient moving forward. Staining: DAPI (blue), SPC (green),
CD45 (red), and F4/80 (red). Images were produced using light microscopy on 40X
objective magnification.
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BMDCs Can Engraft In the Lung As Type II Pneumocytes
As a re-exploration of previously published data with newer more rigorous
methods, we attempted to determine if BMDC could engraft as T2 pneumocytes in
the lungs of transplanted mice. Following lethal irradiation of 1000cGy and
transplantation of 106 WT WBM cells, the recipient mice were evaluated for lung
epithelial engraftment three months later. SPC was used as a marker for donorderived cells since the donor mice were wild type for SPC while the recipients were
SPC knockouts. Also included in the study were WT and SPCKO untransplanted
controls along with a transplantation control of SPCKO into SPCKO (refer to Figure 1
for more details).
In almost 25% of the WT into SPCKO transplants, BMD T2 pneumocytes
could be detected using immunofluorescence (refer to Table 2). These cells were
SPC+CD45-F4/80- in either paraffin or cytospin sections. It should be noted that
these single cell digestion cytospins were red blood cell lysed as well as
immunodepleted using CD45 and CD11b (macrophage/monocyte specific marker).
This greatly enhanced our ability to find epithelial cells of the lung parenchyma. The
typical appearance of these cells is shown in Figure 7. Unfortunately, the number of
BMD T2 pneumocytes in any given animal was exceedingly small. The number of
cells ranged from 1-3 per 5 micron section which contained approximately 70,000
nucleated cells. As a point of reference, for WT mice about 20% of nucleated
alveolar epithelial cells and 7.91% of total DAPI nuclei were SPC positive, which is
consistent with previously published results (80).
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Mouse Type

N
21

Number of Mice with
SPC+CD45-F4/80- Cells
5

Percentage of Mice with
SPC+CD45-F4/80- Cells
24%

Mean Percentage of
Cells that were SPC+
0.002%

WT→SPCKO
SPCKO→SPCKO

5

0

0%

0.000%

WT Control

5

5

100%

7.91%

SPCKO Control

5

0

0%

0.000%

Table 2: BMD Type II Pneumocytes Can Be Seen In WBM Transplants
Using immunofluorescence on either paraffin sections or immunodepleted cytospin
slides, 24% of mice transplanted with WBM were able to demonstrate at least a very
low level of epithelial engraftment as T2 pneumocytes. The level of engraftment was
quantified to be approximately 0.002% of T2 cells based on SPC immunostaining
compared to 0.000% in both the transplantation SPCKO→SPCKO negative control
and 0.000% in the untransplanted SPCKO negative control.
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Figure 7: Sample Paraffin and Cytospin Sections Demonstrating Engraftment
Paraffin sections (left panels) and cytospins (center panels) demonstrating rare
SPC+CD45-F4/80- cells suggestive of a donor-derived T2 cell (arrows). WT image
represents the untransplanted positive control. SPCKO is the untransplanted
negative control. SPCKO→SPCKO is the transplantation control of radioprotection
SPCKO WBM cells only. High magnification images of the WBM transplants (right
panels) are also shown to demonstrate the vesicular nature of SPC staining.
Staining: DAPI (blue), SPC (green). Antibodies against CD45 (red) and F4/80 (red)
for hematopoietic cells and macrophages, respectively, were included to indicate
blood cells. Yellow cells are autofluorescent erythrocytes and macrophages. Images
were produced using light microscopy on 40X objective magnification.
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FLH and LSK Transplants Engraft in The Lung
Based on current available evidence, it is not clear if purified bone marrow cells
offer an engraftment advantage in the lung compared to whole bone marrow. We
therefore sought to answer this question using two well described populations which
are known to be enriched for HSCs. Unfortunately, ELH cells could not be isolated due to
a non-functional elutriator. However, a percoll fractionation technique has been shown
to yield a theoretically similar subpopulation as the elutriation separation (81). These
cells were therefore referred to as fractionated, lineage-depleted, and homed (FLH).
Like ELH cells, FLH cells were shown to home to the bone marrow and provide longterm hematopoietic reconstitution. However, it remains an open question if FLH cells
are truly identical to ELH cells. The second purified population studied was the well
defined LSK group which is separated by FACS using cell surface markers. Utilizing a
similar method as before, mice were lethally irradiated with 1000cGy and then

transplanted and evaluated for lung epithelial engraftment three months later. The
only difference in the methods was that 103 FLH or LSK cells derived from WT mice
were transplanted along with 105 radioprotection cells (which are short term
reconstituting WBM cells identical to the recipient SPCKO). These radioprotection
cells are necessary for animal survival following irradiation and have a lifespan
maximum of 3 months. Therefore at the time of analysis these cells should have
minimal influence on engraftment.
Sex-mismatched transplants were done (i.e., female BMDC into male
recipients) so that hematopoietic engraftment could be assessed at sacrifice using YFISH on peripheral blood smears or bone marrow cytospins. Positive (male) and
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negative (female) controls showed >99% and <1% Y-chromosome positive cells
respectively. When this blood chimerism was examined 1 month post-transplant, 3
of 5 animals transplanted with FLH cells and 3 of 5 animals transplanted with LSK
cells showed greater than 5% chimerism (refer to Table 3). As controls, 4 of 4
animals that received WT WBM and 4 of 5 animals that received SPCKO WBM had
significant levels of hematopoietic engraftment. These quantifications were based
on counting a minimum of 100 nucleated cells per slide. The greater levels of
engraftment in the control groups correlated with the larger number of donor cells
administered during transplantation. As suggested in the literature, despite the
small numbers of animals in this study, it appeared that both FLH and LSK
populations were equally capable of reconstituting the hematopoietic system.
Although there was not a clear correlation between blood chimerism and
identification of marrow-derived pneumocytes, the two animals that demonstrated
the highest level of hematopoietic chimerism were also the only two animals to have
donor derived cells on both paraffin and cytospin sections.
When examining the paraffin and cytospin sections of the lung using
immunofluorescence for SPC, BMD T2 alveolar cells could be detected in both FLH
and LSK transplantation groups (Table 3). In fact, 4 of 5 mice in the FLH group and 5
of 5 in the LSK group had at least 1 positive cell in either of the sections. In
comparison, 2 of 4 mice in the positive control WT WBM group and 0 of 4 in the
negative control SPCKO WBM→SPCKO contained at least 1 positive cell. Therefore
FLH and LSK cells types show a slight enrichment for engraftment when compared
to controls. It should be noted that the positive control WT WBM cytospins were
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unavailable and therefore epithelial engraftment rates are likely higher than 50% if
all the sections could be analyzed. Taking this into account, the data suggest that the
LSK and FLH populations engraft at least as well as WBM.
Despite these promising results, it should be noted that no greater than 2
BMD T2 cells were observed on any one slide. Thus, these conversion events
occurred in most animals but they were very rare. Surprisingly, there was no
pattern between positive cytospin and positive paraffin results. Animals which were
positive in one cell preparation type were not positive in the other except in the 2
instances explained above with the FLH mice showing the highest levels of
hematopoietic engraftment. It is particularly unusual that there was no overlap in
the LSK group. Beyond this, the number of positive cells seen in any one animal was
never greater than 3. Sample images of positive BMD T2 pneumocytes from the FLH
and LSK transplants are presented in Figure 8.
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Figure 8: Representative Paraffin and Cytospin Sections from FLH and LSK
Transplants Show Engraftment in the Lung
These rare BMD engrafted cells appeared similar to the untransplanted positive
control WT type II pneumocytes. Staining: DAPI (blue), SPC (green), CD45 (red), and
F4/80 (red). Images were produced using light microscopy on 40X objective
magnification.

Quantitative PCR for SPC Shows Insignificant Increases Following
Transplantation of BMDCs
To further assess engraftment of BMDC and subsequent transformation of
phenotype, quantitative PCR (qPCR) for SPC was used as a very sensitive marker for
functional T2 cells. Following sacrifice, total RNA from the mouse lung was isolated
and then reverse transcribed into cDNA. This total lung cDNA was then assessed for
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the quantity of SPC transcripts and normalized to total genetic content using 18s
rRNA as the standard. Since only donor-derived cells have a functional SPC gene,
any signal for SPC must have originated from these cells. qPCR is very susceptible to
inconsistent results based on even minute changes in the quantity and quality of
template so three control groups were used and all amplifications were performed
in triplicate. WT served as the positive control and maximal amount of SPC while
SPCKO was the negative control and the minimal amount of SPC. A group of SPCKO
WBM cells into SPCKO mice was included to act as a negative control for irradiation
and transplantation itself.
WBM and LSK transplants did not show a significant difference in the level of
SPC RNA when compared to SPCKO. Interestingly and unexpectedly, SPCKO→SPCKO
control and FLH populations demonstrated a greater amount of SPC RNA on the
order of 100 to 200-fold, respectively. However, it is unclear how the
SPCKO→SPCKO group had higher levels of SPC since the transplanted cells were
SPCKO. Since the difference in SPC RNA was not significant (p=0.38) between the
negative control SPCKO→SPCKO group and the FLH group, it was determined that
no considerable amount of engrafted BMD T2 cells could be detected.
Upon further review of the project design, the FLH and SPCKO→SPCKO
transplantations were performed on the same day in parallel. Therefore, this
unexpected data could be the consequence of cross-contamination of WT FLH
populations into SPCKO WBM animals resulting in a spuriously high qPCR signal in
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the SPCKO→SPCKO group. Alternatively, there could also have been crosscontamination during RNA preparation but this explanation is less likely.
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Figure 9: qPCR for SPC Demonstrating No Significant Difference in mRNA
Levels Between Negative Controls and Transplanted Populations.
Even though the FLH population showed the greatest reconstitution of SPC signal it
was not significantly higher than the SPCKO WBM→SPCKO negative transplantation
control (p=0.38). Therefore, engraftment of BMD T2 cells could not be detected
using these methods. Lower –Delta C(t) levels represent more mRNA transcripts.
WT is the untransplanted positive control showing normal levels of SPC transcripts
and SPCKO is the untransplanted negative control showing no SPC. Total RNA
content normalized to 18s rRNA standard. Each dot represents 1 animal with the
qPCR performed in triplicate.
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Type

Number

% Chimerism by Y-FISH

Cytospin

Paraffin

qPCR -Delta C(t)

FLH

877

1.55 (Blood)

Negative

Positive

22.77

FLH

878

3.13 (Blood)

Negative

Negative

25.84

FLH*

884

46.88 (Blood)

Positive

Positive

31.47

FLH

892

16.67 (Blood)

Negative

Positive

23.17

FLH

893

48.67 (Blood)

Positive

Positive

24.04

LSK

1028

10.17 (BM)

Positive

Negative

31.93

LSK

1029

16.13 (BM)

Negative

Positive

32.54

LSK

1035

6.76 (BM)

Positive

Negative

32.99

LSK

1044

2.78 (BM)

Negative

Positive

32.83

LSK

1054

3.73 (BM)

Positive

Negative

33.49

SPCKO

876

4.63 (BM)

Negative

Negative

24.03

SPCKO

879

8.93 (BM)

Negative

Negative

23.30

SPCKO

880

26.92 (BM)

Negative

Negative

25.63

SPCKO

890

5.13 (BM)

Negative

Negative

26.47

SPCKO

891

Positive (BM)

Negative

Negative

25.17

WBM

M35

Positive (BM)

Unknown

Positive

27.51

WBM

M38

Positive (BM)

Unknown

Negative

28.11

WBM

M40

Positive (BM)

Unknown

Positive

29.20

WBM

1014

5.92 (BM)

Negative

Negative

33.16

Table 3: Summary of All Mice Transplanted for HSC Plasticity Studies
This table presents an overview of the data from each mouse transplanted in this
experimental study. "Type" refers to the population of donor cells transplanted for
this group. SPCKO is the transplantation negative control of SPCKO WBM while
WBM is the transplantation positive control of WT WBM. "Number" is the animal
identifier. Hematopoietic chimerism is shown as a percentage except where the
specifics of this data were unavailable. The source of cells for Y-FISH analyses is
shown in parentheses. Cytospin and paraffin sections of each mouse's lung were
quantified as "positive" if donor-derived T2 cells could be identified and "negative"
if no cells could be found. Some data were unavailable and therefore described as
unknown. The final column shows the raw qPCR data for SPC. *This mouse was
sacrificed at an earlier time point and its qPCR data was not consistent with the
other animals in its group but it is still presented here for completeness.
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FACS Sorting Allows Isolation of Rare Donor-Derived Type II Cells
Based on the rarity and difficulty of identifying engrafted T2 cells in paraffin
sections and cytospins, we sought a different method to search for these events.
Therefore, we investigated whether FACS analysis of the whole digested lung would
be able to separate the cells of interest and allow further investigations on this rare
population of transformed cells. Using a constitutively active GFP reporter mouse as
a donor, 106 WBM cells were transplanted into a lethally irradiated wild type
recipient. At six months post-transplant, the mice were sacrificed and their lungs
digested in the usual fashion with erythrocyte lysis but no other methods of
immunodepletion. In order to isolate donor-derived lung epithelial cells, we had to
gate for GFP+ cells as well as eliminate contaminating populations. In particular,
cells that have high levels of expression of CD45, CD11b, and CD31 (a surface
marker specific for endothelial cells) were excluded.
The results of this FACS analysis showing 106 events can be seen in Figure
10. A WT mouse represents the negative control for GFP expression and the positive
control for total lung epithelial cells. A constitutively GFP-expressing mouse serves
as the positive control for GFP staining. The GFP transplanted mice showed a nearly
100-fold increase of GFP+CD45-CD11b-CD31- cells (0.29%) over background as
represented by the WT mouse (3.5 X 10-3 %). This transplanted population
represented 27% of the theoretical maximum of 1.06% seen in the GFP mouse.
Additionally, a comparable number of total epithelial lung cells were seen in all
three mice (24.5%-32.7%). These data demonstrated that we can successfully
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separate and enrich our target population for BMD lung epithelial cells using FACS
analysis.
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Figure 10: FACS Data Demonstrating 100-Fold Enrichment of GFP+CD45CD11b-CD31- Fraction Containing BMD Lung Epithelial Cells Over Background
Levels
FACS data from one million lung cells showing GFP (Y-axis) and CD45/CD11b/CD31
(X-axis) fluorescence. These data were the clearest of four GFP into WT sorts which
utilized 10 animals. The target population (GFP+CD45-CD11b-CD31-) is in the oval
with quantification. There is an approximately 100-fold enrichment when sorting
for lung epithelial cells compared to background as represented by the WT mouse.
About 27% of maximal target population can be isolated using this method. These
data show that BMD lung epithelial cells can be successfully isolated in significant
numbers using FACS as seen by the clear finger-like projection in the center panel.
"WT" (left panel) represents the untransplanted negative control for GFP staining.
"Transplanted" (center panel) represents the experimental set of GFP-expressing
WBM transplanted into a wild type recipient. "GFP" (right panel) is the
untransplanted positive control for GFP staining.
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Imaging of FACS-Sorted Populations Confirms Lung Engraftment
Following the isolation of lung epithelial cells using FACS, we next sought to
query these cells' phenotype using immunofluorescence microscopy. An additional
FACS sort was performed using five WT mice that were lethally irradiated and then
given 106 ubiquitin-C GFP WBM cells. As expected, these five mouse lungs yielded
approximately 10 million total cells. The resulting GFP+CD45-CD11b-CD31- fraction
from these transplants was 50,000 cells (0.5%) compared to 289,000 GFP+CD45CD11b-CD31- cells out of 4 million total cells (7.2%) for the unirradiated GFP+
positive control. The 50,000 cells were plated onto poly-L-lysine coated glass
bottom dishes and then fixed, stained, and analyzed. Ideally, this sorted population
would contain T2 lung cells which are easily visualized. Using confocal microscopy,
indeed BMD T2 pneumocytes could be visualized as GFP+SPC+ (refer to Figure 11).
However, these double positive cells were exceedingly rare and only 5 convincing
cells (0.01%) were visualized. In contrast, the positive control GFP+ mouse yielded
approximately 25% of cells that were GFP+SPC+ while the SPCKO negative control
mouse yielded 0% double positive cells. This FACS method represents a 5-fold
enrichment (0.01% vs. 0.002%) for our donor-derived T2 cells of interest compared
with examining paraffin sections. The successful use of FACS purification to
separate, enrich, and visualize BMD lung epithelial cells enabled a significantly more
thorough and easier method to analyze the entire lung for rare engraftment events.
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Figure 11: Confocal Microscopy Showing BMD Type II Pneumocytes that Were
Purified by FACS
Immunofluorescence of the FACS sorted CD45-CD11b-CD31- population for GFP and
SPC. GFP (green) denotes donor derived cells while SPC (red) is the marker for T2
lung cells. Nuclei are stained with DAPI (blue). Double-positive cells (GFP+SPC+)
could be seen in the GFP transplants, which are suggestive of donor-derived T2 cell
engraftment. "SPCKO" is the negative control for SPC and GFP staining. "WT" is the
positive control for SPC staining and another negative control for GFP staining.
"GFP+ control" is the positive control for both GFP and SPC staining. "GFP
Transplants" is the experimental set of GFP-expressing WBM transplanted into a
wild type recipient. Images created by Susannah Kassmer using 63X objective
magnification.
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Engraftment in the Lung May Be Greater Among the Hematopoietic
Fraction of BMDCs and May Be Enhanced by a Second Dose of
Radiation
As explained in the Introduction and presented in Table 1, there remains an
important and ongoing debate concerning which BMD cell population demonstrates
the most plasticity. Multiple groups claim that HSCs with their regenerative
potential are the cell of interest for these conversions, while others purport that
non-hematopoietic MSCs frequently migrate to epithelial tissue and adopt a novel
phenotype. In an effort to better describe these cell populations and directly
compare their engraftment potential, we made use of vav ancestry mice, which
allow the faithful and permanent expression of a YFP transgene if a cell ever
expressed the hematopoietic-specific vav promoter. SPCKO recipient mice were
lethally irradiated and then systemically administered cells from one of three bone
marrow populations isolated from vav-Cre YFP mice: 106 unsorted WBM as a
positive control, 2 X 106 FACS-sorted YFP+ cells representing the hematopoietic
fraction, or 5 X 105 FACS-sorted YFP- cells representing the non-hematopoietic
fraction along with 106 SPCKO unsorted WBM (refer to Methods and Figure 2 for
details). The third group required supplemental SPCKO WBM because the YFPpopulation does not otherwise contain hematopoietic cells and without them the
irradiated recipient animals would have succumbed to radiation toxicity. The
differing number of cells transplanted is the result of the number of cells yielded
during FACS sorting. Overall, these differences were not large and should not
significantly impact our outcomes. These mice were then sacrificed and evaluated
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for lung epithelial engraftment one month later using similar methods to the
previous transplants. As before, SPC mRNA and protein were used as reporters for
donor-derived cells.
Sex-mismatched transplants were again employed to evaluate hematopoietic
engraftment using Y-FISH on bone marrow cytospins. When this blood chimerism
was examined by counting 300 cells per slide, all transplanted animals showed
greater than 97% engraftment. This extremely robust engraftment means that
essentially the entire hematopoietic system was reconstituted by the donor cells.
However, the YFP- population cannot truly be evaluated by hematopoietic
engraftment since it does not contain blood-forming cells. To solve this problem, we
assessed the short-term hematopoietic engraftment of the co-transplanted SPCKO
radioprotection cells as a proxy for YFP- cell survival during transplantation.
Although this is not an ideal method, it was the only available strategy.
Unfortunately, cytospins of these transplants were unreliable with large
amounts of background fluorescence and fragmented cells. Therefore, only paraffin
sections of the lung were used for immunofluorescence to detect SPC signal and
therefore donor-derived T2 cells. Since most of these mice were transplanted with
YFP+ blood cells, we evaluated autofluorescence on these slides before adding
primary antibody to ensure that it did not confound the subsequent staining and
yield false positive results. Indeed, following antigen retrieval, the native YFP signal
produced a very low background which could not be confused with positive staining
results in either the blue, green, or red channel.
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Surprisingly, the paraffin sections of these transplants yielded no convincing
donor-derived T2 pneumocytes in any of the transplantation groups (refer to Table
4). This most likely was the consequence of the small numbers of animals in each
group which survived to analysis. Therefore, another investigator in the lab has
subsequently replicated these results with the same outcome (data not shown). This
was unanticipated since we expected to see the same level of engraftment as during
the earlier WT WBM transplantation studies in which 1 out of 4 mice showing signs
of donor cell engraftment on paraffin section. However, the vav-Cre YFP WBM group
did not have a single SPC+CD45-F4/80- cell by immunofluorescence on paraffin
sections. In light of this data, lung cytospins would certainly have been useful to
corroborate the negative results.
Faced with these disappointing results, we attempted to enhance any level of
conversion by targeting the right lung of the remaining transplantation animals to a
second dose of radiation. This salvage strategy was based on the possibility that we
had not reached the threshold of injury that is necessary for BMDC engraftment
(40). The left lung was shielded from further damage and served as an internal
negative control. One month following this second dose of lethal irradiation, the
mice were sacrificed and analyzed.
When immunofluorescence on paraffin lung sections of these animals was
studied, 1 of 4 animals in the vav-Cre YFP WBM group and 1 of 3 animals in the vavCre YFP+ group demonstrated an SPC+CD45-F4/80- cell in the right lung indicative
of T2 epithelial engraftment (refer to Table 4). No greater than two engrafted cells
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were detected in either animal. None of the internal control left lungs or
transplantation control SPCKO→SPCKO lungs showed any donor-derived T2
alveolar cells. Interestingly, both of the YFP WBM and the sorted YFP+ populations
contain the hematopoietic elements of the bone marrow and showed signs of
engraftment while the non-hematopoietic sorted YFP- population did not. It is also
suggestive that the second radiation dose enhanced engraftment but both these
conclusions must be tempered by the low animals numbers and lack of statistical
significance in this study.

qPCR for SPC Shows a Significant Increase Following
Transplantation of the FACS-Sorted YFP+ Population Only In the
Mice that Received a Second Dose of Radiation
In an effort to further evaluate and correlate epithelial engraftment levels,
qPCR for SPC was used as before. Following RNA isolation and reverse transcription,
whole lung cDNA was evaluated by qPCR for the quantity of SPC transcripts in the
various transplantation groups. Total genetic content was normalized using the
ubiquitous β2-microglobulin gene as the standard. WT served as the positive control
and maximal amount of SPC. A group of SPCKO mice which received SPCKO WBM
was included as a negative control for irradiation and transplantation itself.
All the mice in the groups that received unsorted vav-Cre YFP WBM or sorted
YFP- cells showed minimal levels of SPC signal similar to the negative control
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SPCKO→SPCKO transplants (Figure 12). Although the number of control animals is
small, the transcript levels of SPC and β2 were consistent with values from
subsequent experiments. Both primary and secondary irradiated animals showed
similar results and are presented together (Table 4). However, 2 of the 5 mice in the
sorted vav-Cre YFP+ group showed significantly higher levels of SPC transcripts
(p=0.009) in the right lung. Both of these animals had received a secondary dose of
targeted right lung irradiation. The mean –Delta C(t) for these two mice were 13.62
and 13.25 compared with 17.20 for the transplantation negative control. This result
represents an approximately 13-fold higher level of SPC signal suggesting that the
hematopoietic vav-Cre YFP+ population has some engraftment potential as
functional T2 pneumocytes in the lung. This greater expression was only present in
the right lung of these animals so it is possible that the second dose of radiation
enhanced an epithelial engraftment phenotype. Unfortunately, this level of SPC
expression still pales in comparison to the WT positive control which is 2 X 107
times greater.
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Figure 12: qPCR for SPC Demonstrating Two Animals in the YFP+ Group with
Significant Increases in Transcript Levels Suggestive of Engraftment
The vav-Cre YFP WBM and FACS-sorted YFP- transplantation groups showed levels
of SPC mRNA consistent with the transplantation negative control SPCKO→SPCKO.
But, in the FACS-sorted vav-Cre YFP+ population, 2 mice which both received
additional radiation showed significantly greater levels of SPC transcript (p=0.009)
indicating possible BMD functional T2 cells. Lower –Delta C(t) levels represent more
mRNA transcripts. WT is the untransplanted positive control showing normal levels
of SPC transcripts. Total RNA content normalized to β2-microglobulin standard.
Each dot represents 1 lung with the qPCR performed in triplicate.
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Type

Number

WBM

978

WBM

980

WBM

985

WBM

986

WBM

987 R

X-Ray
Y

Y

987 L

Blood Chimerism by Y-FISH

Paraffin

qPCR -Delta C(t)

Positive

Negative

21.66

Positive

Negative

19.27

Positive

Negative

19.79

Positive

Negative

18.80

Positive

19.96

Negative

21.98

Positive

WBM

995

Y

Positive

Negative

17.08

WBM

990

Y

Positive

Negative

21.12

YFP+

982

Y

Positive

Negative

21.70

983 R

Y

Negative

13.62

Negative

20.63

Negative

21.38

Positive

13.25

Negative

23.64

YFP+
YFP+
YFP+

983 L
991
992 R

Positive
Positive

Y

992 L

Positive

YFP+

993

Positive

Negative

20.38

YFP-

984

Positive

Negative

20.60

YFP-

989

Positive

Negative

20.26

SPCKO

SPCKO1

Positive

Negative

17.70

SPCKO

SPCKO2

Positive

Negative

16.71

Y

Table 4: Summary of All Mice Transplanted For the Vav Ancestry and
Secondary Irradiation Studies
This table presents an overview of the data from each mouse transplanted in this
experimental study. "Type" refers to the population of donor cells transplanted for
this group. "Number" is the animal identifier with "R" and "L" meaning right and left
lung respectively. "X-ray" represents a second dose of targeted irradiation to the
right lung of the mouse. Any animal which showed positive signs of engraftment on
either the paraffin sections or qPCR quantification was then compared to the
contralateral lung (which represents an internal control). SPCKO is the
transplantation negative control of SPCKO WBM while WBM is the transplantation
positive control of vav-Cre YFP unsorted WBM. Hematopoietic chimerism, as seen
on BM cytospins, was greater than 97% in all animals shown. Paraffin sections of
each mouse's lung were quantified as "positive" if donor-derived T2 cells could be
identified and "negative" if no cells could be found. The final column shows the raw
qPCR data for SPC.
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DISCUSSION
Detection Strategies
In an effort to better understand the plasticity and engraftment potential of
BMDCs in the lung, we undertook multiple studies to evaluate the presence of
donor-derived T2 pneumocytes. The initial weeks of this project were focused on
demonstrating our immunofluorescence detection strategy for SPC was viable.
Indeed, using a protocol lacking an antigen retrieval step coupled with a guinea pigraised polyclonal antibody, type II pneumocytes could be consistently recognized by
their characteristic vesicular SPC staining during microscopy on both paraffin
section and cytospins. These methods were then applied to SPCKO mice which had
been lethally irradiated and systemically transplanted with WT WBM.
Approximately 24% of these animals demonstrated SPC+CD45-F4/80- T2 cells on
microscopy. However, the absolute number of these donor-derived cells was very
small with only 0.025% of resident T2 cells being engrafted from the donor. This
number was calculated by dividing the mean percentage of SPC+ cells in the
transplants by the mean percentage of SPC+ cells in the WT control. Although this
minute level of engraftment was reproducibly detectable with our techniques, we
realized that additional analyses would be helpful in finding these conversion
events.
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There were other technical challenges to this phase of the project and thus
our interpretation of results. Frequently, we observed different levels of tissue
fixation and agarose inflation despite identical methods. Tissue fixation was
probably affected by the surface area to volume ratio of each lung as well as time
spent in 70% ethanol prior to paraffin embedding. With tissues that were overfixed,
the edges of the lung showing high levels of background immunofluorescence. This
made the detection of SPC positive cells virtually impossible in certain regions.
Although this problem was not extensive, it did obscure a perfectly consistent
examination of every slide. During lung preparation, agarose inflation was
determined to be an essential step to recapitulate the functionally-relevant inflated
architecture of the lung. Unfortunately, this required a tight seal between the
angiocatheter and the trachea which was not always possible. The resulting
underinflated lungs had high cell densities that distorted morphology and made
analysis more difficult due to indistinct cell borders and overlay. By necessity, these
questionably positive cells were deemed negative since conclusive microscopic
evidence could not be demonstrated. Although these issues made analysis more
complicated and skewed toward the negative, they were relatively minor and did
not impact our conclusions in any meaningful way.

FLH and LSK Populations
The FLH and LSK transplantation groups showed levels of lung engraftment
greater than the control WBM populations when examining immunofluorescence.

DISCUSSION

COHEN 67

This result tentatively suggests that these hematopoietic subpopulations are
enriched for cells capable of making the transition to T2 alveolar cells of the lung.
However, it is difficult to definitively make these conclusions because of the small
numbers of animals and rarity of positive donor-derived cells in these studies.
Additional transplantations would be necessary to prove that this outcome is truly
significant.
Unfortunately, qPCR data for SPC did not reinforce this trend that FLH and
LSK populations showed greater levels of engraftment. But this statistical
insignificance was dependent on the negative transplantation control of SPCKO
WBM→SPCKO mice. It seems likely that this group was accidentally contaminated
during transplantation with WT FLH cells, which were also being isolated and
transplanted on the same day. The untransplanted SPCKO mice should have shown
the same minimal levels of SPC signal as the negative transplantation control. But
our data show a significantly greater level of SPC (greater than 100-fold) in this
transplantation group.
An alternative hypothesis for this false upregulation of SPC is that irradiation
and transplantation itself (regardless of cell type administered) induces pseudogene
expression. Despite the exquisite specificity of the SPC qPCR primer design, it is still
possible that an unintended similar target sequence is being amplified erroneously.
This hypothesis can be tested using standard gel electrophoresis to confirm that the
qPCR product is of the expected 664 base pair size. However, this was not
undertaken because of time constraints and the unlikelihood of pseudogene
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expression. Since the other transplantation groups (WT WBM and LSK), which were
performed on different days, did not show the same effect and clustered around the
untransplanted negative control, it is difficult to support this pseudogene theory.
Interestingly, if the SPCKO WBM→SPCKO transplantations were repeated
and showed the expected minimum of SPC signal, then the FLH population and a few
of the WBM transplants (to a lesser degree) would show significantly higher levels
of SPC. This result would correlate with the previous staining data and lend further
evidence to the hypothesis that HSC subpopulations are enriched for pluripotent
cells capable of epithelial engraftment.

FACS Sorting for Engrafted Type II Pneumocytes
Our investigation showed that FACS sorting the enzymatically digested lung
was a viable strategy for selectively isolating lung epithelial cells. In fact, the
calculated total number of alveolar cells (24.5%) as well as the number of T2
pneumocytes (6.1%) in the lung compared very favorably with previous estimates
using microscopy and immunostaining (20% and 7.9%, respectively). Therefore,
this technique allowed us to greatly enrich for alveolar cells such that all possible
donor-derived cells of interest could be examined on a single dish. This greatly
reduced the likelihood that true engraftment events were missed because of
random sampling. Of course, cytospins from these sorts are not the only method
that should be applied to these investigations because unfortunately cell
morphology and histology are lost during preparation. However, this method does
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have the added benefit of reducing overlay artifacts and background
immunofluorescence. As we look forward and design future experiments, FACS
sorting will certainly be one of the modalities employed to find these extremely rare
conversion events.

Vav-Cre Ancestry Populations and Secondary Irradiation
It was surprising that the initial evaluations of engraftment from all three vav
ancestry mouse populations were negative by both immunofluorescence and qPCR.
However, the fact that a second dose of targeted irradiation was able to induce
engraftment subsequently in a few animals suggested that the required threshold of
damage was not initially achieved. It is not clear why this second dose was needed
in these groups because they initially received sufficient radiation to reconstitute
the hematopoietic system with donor cells. However, the use of a contralateral lung
control that was shielded from this secondary dose provides strong evidence that
the additional radiation was essential for inducing engraftment. In addition to
inducing engraftment, these secondarily irradiated animals had subjectively higher
levels of tissue damage with an elevated number of macrophages and increased
fibrosis. Previous research has shown that the number of SPC-expressing T2 cells
typically decreases along with surfactant levels with repeated irradiation (82),
which makes it all the more striking that significantly greater levels of engraftment
were seen.
Although the numbers of animals used in this study were small, our data hint
that the YFP+ hematopoietic components of the bone marrow are able to engraft at
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least as well as the control WBM while the YFP- non-hematopoietic cells were not.
When taken with the previous conclusions from the LSK and FLH experiments, it
looks as if the HSC subpopulation contains the plasticity necessary to engraft as type
II pneumocytes in the lung. But before these hypotheses are proven definitively,
additional transplantations must be performed especially using the YFP- vav
ancestry population. To further enhance these studies and complement the paraffin
section and qPCR results, FACS sorting of digested lungs should be employed to
provide a reliable and powerful method to find rare donor-derived cells by
immunofluorescence.

The Difficulties in Demonstrating Plasticity
Throughout all our transplantation examinations, our detection strategies
skew heavily towards the null hypothesis that donor-derived T2 cells do not exist.
Transplantation itself places remarkable challenges on the donor cells. They were
asked to exist outside of an organism for hours in varying reagents while they were
being isolated, purified, and prepared for injection. These transplanted bone
marrow cells were then required to home from the vasculature to their natural
niche while also competing with the radioprotection SPCKO cells.
Beyond this, engraftment as an epithelial cell required the establishment of
an obvious phenotype with wholesale genetic program modifications such that
hematopoietic genes were silenced and epithelial markers were upregulated.
Specifically, we only detected cells that express the very particular SPC target gene.
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In fact, a possible explanation for the low level of SPC signal was its immunologic
recognition by the recipient SPC knockout mice as a foreign mRNA and protein.
Western blot analysis remains the standard for protein expression studies and
would have been utilized here; but previous work demonstrated that SPC protein
levels were too low for consistent detection.
Additionally, we utilized a high degree of skepticism when examining every
potentially SPC-positive cell. Even the positive control WT mouse had many T2 cells,
which would not be considered positive because they weren't definitely clear
examples of an SPC-positive staining pattern. This placed a great onus on the
engrafted cells to not only express SPC but also express it in the classically
recognized morphology. Given all these challenges both biologically and technically,
it is amazing that any positive cells could be found.
Additional T2 cell-specific antibodies, such as the nuclearly localized thyroid
transcription factor 1 (83) or cytokeratin-7, might be included for future
immunofluorescence studies to reduce the ambiguity of certain positive cells. But
this carries with it further challenges such as using another non-overlapping color
channel for detection. Also it complicates analysis because it reduces the likelihood
of finding a cell which definitely and characteristically expresses both phenotype
markers.
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The Mechanisms of Plasticity
The possible mechanisms responsible for BDMC plasticity remains a hotly
debated topic with little consensus in the literature. The first option, which has been
already alluded to in the previous section, is transdifferentiation in which one
committed cell type has the ability to changes its phenotype and gene expression
profile to that of an entirely different cell type. This theory is derived from in vivo
studies conducted with plants in which photosynthetic mesophyll cells isolated from
zinnia leaves transdifferentiate into xylem cells (84) and with animals in which
amphibians such as newts are able to undergo limb regeneration (85). Using in vitro
methods, there are also multiple reports of terminally differentiated somatic cell
phenotype switching from pancreatic epithelium to hepatocytes (86) and fibroblast
to T-cell (87). Most recently, the discovery of and ensuing work with induced
pluripotent stem (iPS) cells has deconstructed the idea of non-reversible cell
commitment by showing that many mature cell types are able to be transformed
into embryonic-like stem cells capable of producing all three germ layers in addition
to chimeric animals (88-92).
A priori it is reasonable to hypothesize that systemically delivered BMDC
would become entrapped in highly arborized capillary networks such as found in
the lung. These donor cells then receive local cellular signals from their newly
established niche driving adaptation to the resident tissue. If this mechanism were
taking place, it is reasonable to assume that donor derived cells would be found in
other capillary networks which is in fact the case as explained in the Introduction.
Additionally, a dose response curve would be evident such that greater levels of
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epithelial engraftment would be seen with greater numbers of cells transplanted.
This experiment has yet to be performed but it offers an opportunity to examine this
hypothesis. Our work does not show a clear correlation between donor
hematopoietic reconstitution and levels of epithelial engraftment but these outcome
measures may be unrelated to transdifferentiation capacity.
Alternatively, there could be a previously undescribed highly pluripotent
BMDC population that has not committed to becoming blood and therefore has the
ability to self-renew as well as differentiate into hematopoietic stem cells and
epithelial cell lineages. Among the suspected populations are multipotent adult
progenitor cells (MAPCs)(93) and very small embryonic-like cells (VSELs)(94, 95).
The third possible mechanism for plasticity could be the fusion of a BMDC
with a non-hematopoietic cell to form a heterokaryon, which has the gene
expression profile of the fusion partner. The two most documented examples are:
when a fibroblast fuses with a myoblast to form a heterokaryon, the fibroblast
nuclei expresses muscle-specific mRNA (96), and during somatic cell nuclear
transfer into unfertilized oocytes, the somatic nuclei undergoes nearly complete
reprogramming (97). More recent data have shown that macrophages have the
ability to fuse with injured hepatocytes in vivo and that the resulting macrophage
nucleus expresses liver-specific transcripts (98, 99). Lastly, previous work in the lab
has shown that 20-50% of BMD epithelial cells in the lung are due to fusion (100).
Therefore, fusion has been shown to be a mechanism by which this conversion takes
places but this does not preclude that other possible mechanisms aren't involved.
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The fourth possibility is based on the newly discovered capacity of cells to
take up microvesicles containing mRNA from other cells (101). This transferred
mRNA can then be detected along with its translated protein in the recipient cell
(102). In fact, uptake and expression of lung epithelial cell-derived mRNA by cocultured BMDCs has been demonstrated (103).

Future Directions
Of course, this thesis represents a work in progress and additional
experiments await completion in order to more fully develop an understanding of
the plasticity of bone marrow derived cells. Questions regarding the kinetics of this
transformation process are still unanswered. "How long does this transition take?"
and "How does the number of engrafted cells change over time?" are relevant
questions which need to be investigated. As discussed in the Introduction, the
transplantation of BMDCs appears to have the greatest clinical benefit in an acute
setting. It seems unlikely that the very low numbers of BMD engrafted cells could
provide a lasting functional benefit. However, how these cells interact with the
native tissue in a long time course has yet to be studied. In order to examine these
questions, we would like to conduct a longitudinal study to examine engraftment at
multiple time points. Using the same methods to complement our three month posttransplantation time point, engraftment data should be collected one week, one
month, six months, and one year after transplantation. The FACS sorting of potential
cells could be of the most benefit here since it was reliable and sensitive enough to
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provide a quantitative measure of these events. I predict that the greatest number of
engrafted cells would be detected in the first week post-irradiation when there is
large scale apoptosis and high levels of circulating cytokines and growth factors. I
suspect that after this initial event the number of engrafted cells drops precipitously
such that at one year no donor-derived epithelial cells can be detected.
The LSK, FLH, and vav-Cre YFP+ hematopoietic populations engrafted at least
as well as WBM in the lungs of transplanted animals. However, these well studied
subpopulations represent a small fraction of the purported stem cell populations
present in the bone marrow. Future experiments would focus on rigorously
studying other bone marrow subpopulations, perhaps not of the hematopoietic
lineage, in order to assess their epithelial plasticity in the lung. In particular,
plasticity experiments involving mesenchymal stem cells (MSC), very small
embryonic-like cells (VSEL), side population cells, and amniotic fluid stem cells are
among the many being discussed in the literature. These populations may hold
exceptional transformation properties as multiple groups have already
demonstrated their multipotent capability (104-108). Essentially, the future
directions of this project will focus on pursuing a starting population of cells which
have the most potential for therapeutic relevance using tissue engineering
principles. Specifically, we will search for the cells type that has the most robust
ability to home sites of injury and contribute to in vivo tissue repair.
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